HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

D 23129 (retigabine)

structure in first source
Also Known As:
retigabine; D 20443; D-20443; D-23129; N-(2-amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester; ethyl N-(2-amino-4-(4-fluorobenzylamino)phenyl)carbamate hydrochloride
Networked: 122 relevant articles (16 outcomes, 23 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Rundfeldt, C: 6 articles (11/2006 - 01/2000)
2. Lerche, Holger: 5 articles (08/2015 - 04/2008)
3. Czuczwar, Stanislaw J: 3 articles (01/2015 - 02/2009)
4. Luszczki, Jarogniew J: 3 articles (01/2015 - 02/2009)
5. Tompson, Debra J: 3 articles (01/2014 - 08/2013)
6. Crean, Christopher S: 3 articles (01/2014 - 08/2013)
7. Gil-Nagel, Antonio: 3 articles (11/2013 - 08/2012)
8. Nohria, V: 3 articles (05/2011 - 04/2007)
9. Husum, Henriette: 3 articles (02/2010 - 01/2008)
10. Fang, Dong: 2 articles (03/2015 - 03/2013)

Related Diseases

1. Seizures (Seizure)
2. Epilepsy (Aura)
3. Neuralgia (Stump Neuralgia)
4. Partial Epilepsies (Epilepsy, Partial)
5. Temporal Lobe Epilepsy
01/01/2011 - "In this systematic review we present information relating to the effectiveness and safety of the following interventions: antiepileptic drugs after a single seizure; monotherapy for partial epilepsy using carbamazepine, gabapentin, lamotrigine, levetiracetam, phenobarbital, phenytoin, sodium valproate, or topiramate; addition of second-line drugs for drug-resistant partial epilepsy (allopurinol, eslicarbazepine, gabapentin, lacosamide, lamotrigine, levetiracetam, losigamone, oxcarbazepine, retigabine, tiagabine, topiramate, vigabatrin, or zonisamide); antiepileptic drug withdrawal for people with partial or generalised epilepsy who are in remission; behavioural and psychological treatments for partial or generalised epilepsy (biofeedback, cognitive behavioural therapy (CBT), educational programmes, family counselling, relaxation therapy (alone or plus behavioural modification therapy, yoga); and surgery for drug-resistant temporal lobe epilepsy ( lesionectomy, temporal lobectomy, vagus nerve stimulation as adjunctive therapy)."
01/01/2010 - "In this systematic review we present information relating to the effectiveness and safety of the following interventions: antiepileptic drugs after a single seizure; monotherapy for partial epilepsy using carbamazepine, gabapentin, lamotrigine, levetiracetam, phenobarbital, phenytoin, sodium valproate, or topiramate; addition of second-line drugs for drug-resistant partial epilepsy (allopurinol, eslicarbazepine, gabapentin, lacosamide, lamotrigine, levetiracetam, losigamone, oxcarbazepine, retigabine, tiagabine, topiramate, vigabatrin, or zonisamide); antiepileptic drug withdrawal for people with partial or generalised epilepsy who are in remission; behavioural and psychological treatments for partial or generalised epilepsy (biofeedback, cognitive behavioural therapy (CBT), educational programmes, family counselling, relaxation therapy (alone or plus behavioural modification therapy, yoga); and surgery for drug-resistant temporal lobe epilepsy ( lesionectomy, temporal lobectomy, vagus nerve stimulation as adjunctive therapy)."

Related Drugs and Biologics

1. lacosamide
2. Anticonvulsants (Antiepileptic Drugs)
3. lamotrigine (Lamictal)
4. etiracetam (levetiracetam)
5. Valproic Acid (Valproate, Semisodium)
6. Carbamazepine (Tegretol)
7. tiagabine (Gabitril)
8. topiramate (Topamax)
9. gabapentin (Neurontin)
10. oxcarbazepine (Trileptal)

Related Therapies and Procedures

1. Vagus Nerve Stimulation
2. Relaxation Therapy
3. Psychology Biofeedback (Biofeedback)
4. Ligation
5. Oral Administration